In an unprecedented national effort, the Deputy President of South Africa Cyril Ramaphosa and the Minister of Health Dr Aaron Motsoaledi today launched the country's biggest ever TB screening campaign that will be rolled-out over five years.

To mark World TB Day, March 24, 2015, the International Journal of Infectious Diseases is publishing a Special Issue that will help raise awareness about the burden of tuberculosis and present a collection of articles by some of the world’s most noted researchers and clinicians. The articles present recent successes and future challenges in the quest to eliminate TB from the planet.

Lack of political commitment will jeopardize momentum for stronger TB action across the region.

A new report by the TB Europe Coalition, “After Aid: What is next for TB and HIV in Europe”, illustrates the potentially devastating impact of donor withdrawal on a range of countries in Eastern Europe and Central Asia, where the tuberculosis and HIV epidemics are still problematic.

​This Expert Opinion outlines some pre-conditions that are considered to be essential at the national level prior to the use of new drugs for the treatment of tuberculosis, as well as specific conditions needed in order to successfully implement new TB drugs/regimens. 

This review outlines challenges in accessing drugs encountered from the perspective of clinicians, patients and affected communities, and offers potential solutions.

This World TB Day, a group of concerned and eminent citizens have written an open letter to Prime Minister Narendra Modi urging him to make TB control a priority in India terming it as a national crisis.

A briefing document outlines critical steps needed to implement a new policy from the Indian government to switch to standard daily TB treatment using fixed-dose combinations. This change, which is in line with global recommendations for proper treatment, is welcome but has yet to be put into action.

New and promising DR-TB drugs are grabbing headlines but not reaching patients.

International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).